Saltar la navegación
Cerrar sesión
Entrar
Cerrar sesión
Entrar
Ken Garber
9
Article
In a Major Shift, Cancer Drugs Go ‘Tissue-Agnostic’
Encouraged by an FDA approval, companies design cancer drugs to work in any solid tumor
Ken Garber
Science, 2017